Cargando…
l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug
Current therapy of mood disorders has several limitations. Although a high number of drugs are clinically available, as of today, nearly two-thirds of individuals do not achieve full symptomatic remission after treatment with conventional antidepressants. Moreover, several weeks of drug treatment ar...
Autores principales: | Chiechio, Santina, Canonico, Pier Luigi, Grilli, Mariagrazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795963/ https://www.ncbi.nlm.nih.gov/pubmed/29267192 http://dx.doi.org/10.3390/ijms19010011 |
Ejemplares similares
-
NF-κB Mediated Regulation of Adult Hippocampal Neurogenesis: Relevance to Mood Disorders and Antidepressant Activity
por: Bortolotto, Valeria, et al.
Publicado: (2014) -
Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-κB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine
por: Chiechio, Santina, et al.
Publicado: (2006) -
l-carnitine and l-acetylcarnitine supplementation for idiopathic male infertility
por: Khaw, Shen Chuen, et al.
Publicado: (2020) -
β(2) and α(2) adrenergic receptors mediate the proneurogenic in vitro effects of norquetiapine
por: Bortolotto, Valeria, et al.
Publicado: (2021) -
Poor Efficacy of L-Acetylcarnitine in the Treatment of Asthenozoospermia in Patients with Type 1 Diabetes
por: Condorelli, Rosita A., et al.
Publicado: (2019)